Ignite Creation Date:
2024-05-06 @ 10:40 AM
Last Modification Date:
2024-10-26 @ 12:34 PM
Study NCT ID:
NCT03324282
Status:
TERMINATED
Last Update Posted:
2022-05-03
First Post:
2017-10-19
Brief Title:
First-line GemcitabineCisplatin - Avelumab in Locally Advanced or Metastatic Bladder Carcinoma
Sponsor:
University Hospital Bordeaux
Organization:
University Hospital Bordeaux
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-02-23
Start Date Type:
ACTUAL
Primary Completion Date:
2021-12-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-01-14
Completion Date Type:
ACTUAL
First Submit Date:
2017-10-19
First Submit QC Date:
October 24 2017
Study First Post Date:
2017-10-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-26
Last Update Post Date:
2022-05-03
Last Update Post Date Type:
ACTUAL